Search for: "MYLAN, INC."
Results 521 - 540
of 674
Sort by Relevance
|
Sort by Date
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on… [read post]
26 Apr 2010, 7:50 am
Mylan Pharmaceuticals, Inc., C.A. [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
15 Apr 2010, 9:20 am
Cir. 1996) (not an FDCA case); Mylan Laboratories, Inc. v. [read post]
15 Apr 2010, 4:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: CAFC denies Vanderbilt’s claim to Cialis patent right: Vanderbilt University v ICOS Corporation (Patently-O) (IPBiz) Paris District Court: Basic patent for Losartan covers any product comprising Losartan: Du Pont v Mylan Losartan SPC case (EPLAW) General WHO documents from counterfeit meeting now online (IP… [read post]
11 Apr 2010, 9:36 pm
• Defendant: Mylan Pharmaceuticals Inc. [read post]
9 Apr 2010, 8:30 am
These companies include Mylan Pharmaceuticals Inc., Roxane Laboratories Inc., and Torrent Pharmaceuticals Ltd. [read post]
31 Mar 2010, 1:58 pm
Prods., Inc. v. [read post]
24 Mar 2010, 4:45 am
Impax Laboratories, Inc. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
5 Mar 2010, 9:10 pm
Mylan Labs., Inc., 520 F.3d 1358, 1364-65 (Fed. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
2 Mar 2010, 5:10 am
Mylan Labs., Inc., 520 F.3d 1358, 1364–65 (Fed. [read post]
18 Feb 2010, 10:34 am
Most notably there’s Mylan Laboratories, Inc. v. [read post]
17 Feb 2010, 8:00 am
Mylan Pharmaceuticals Inc. [read post]
17 Feb 2010, 5:10 am
Trigen Laboratories, Inc (Patent Docs) Tramadol – France: Preliminary injunctions in case of an ‘imminent infringement’: Mylan v Medochemie (EPLAW) [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
